Biology Reference
In-Depth Information
Caroni, P., & Schwab, M. E. (1988). Antibody against myelin-associated inhibitor of neurite
growth neutralizes nonpermissive substrate properties of CNS white matter.
Neuron
,
1
,
85-96.
Chan, C. C., Khodarahmi, K., Liu, J., et al. (2005). Dose-dependent beneficial and detrimen-
tal effects of ROCK inhibitor Y27632 on axonal sprouting and functional recovery after
rat spinal cord injury.
Experimental Neurology
,
196
, 352-364.
Chen, M. S., Huber, A. B., van der Haar, M. E., et al. (2000). Nogo-A is a myelin-associated
neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1.
Nature
,
403
,
434-439.
Crowe, M. J., Bresnahan, J. C., Shuman, S. L., et al. (1997). Apoptosis and delayed degen-
eration after spinal cord injury in rats and monkeys.
Nature Medicine
,
3
, 73-76.
Curt, A., Schwab, M. E., & Dietz, V. (2004). Providing the clinical basis for new interven-
tional therapies: Refined diagnosis and assessment of recovery after spinal cord injury.
Spinal Cord
,
42
, 1-6.
Dergham, P., Ellezam, B., Essagian, C., et al. (2002). Rho signaling pathway targeted to pro-
mote spinal cord repair.
The Journal of Neuroscience: The Official Journal of the Society for
Neuroscience
,
22
, 6570-6577.
Dimou, L., Schnell, L., Montani, L., et al. (2006). Nogo-A-deficient mice reveal strain-
dependent differences in axonal regeneration.
The Journal of Neuroscience: The Official Jour-
nal of the Society for Neuroscience
,
26
, 5591-5603.
Domeniconi, M., Cao, Z., Spencer, T., et al. (2002). Myelin-associated glycoprotein
interacts with the Nogo66 receptor to inhibit neurite outgrowth.
Neuron
,
35
, 283-290.
Fawcett,J.W.,Curt,A.,Steeves,J.D.,etal.(2007).Guidelinesfortheconductofclinicaltrialsfor
spinal cord injury as developed by the ICCP panel: Spontaneous recovery after spinal
cord injury and statistical power needed for therapeutic clinical trials.
Spinal Cord
,
45
,
190-205.
Fehlings, M. G., Theodore, N., Harrop, J., et al. (2011). A phase I/IIa clinical trial of a re-
combinant Rho protein antagonist in acute spinal cord injury.
Journal of Neurotrauma
,
28
,
787-796.
Filbin, M. T. (2003). Myelin-associated inhibitors of axonal regeneration in the adult mam-
malian CNS.
Nature Reviews. Neuroscience
,
4
, 703-713.
Fouad, K., Klusman, I., & Schwab, M. E. (2004). Regenerating corticospinal fibers in the
Marmoset (Callitrix jacchus) after spinal cord lesion and treatment with the anti-
Nogo-A antibody IN-1.
The European Journal of Neuroscience
,
20
, 2479-2482.
Fournier, A. E., Grandpre, T., & Strittmatter, S. M. (2001). Identification of a receptor me-
diating Nogo-66 inhibition of axonal regeneration.
Nature
,
409
, 341-346.
Freund, P., Schmidlin, E., Wannier, T., et al. (2006). Nogo-A-specific antibody treatment
enhances sprouting and functional recovery after cervical lesion in adult primates.
Nature
Medicine
,
12
, 790-792.
Garcia-Alias, G., Barkhuysen, S., Buckle, M., et al. (2009). Chondroitinase ABC treatment
opens a window of opportunity for task-specific rehabilitation.
Nature Neuroscience
,
12
,
1145-1151.
Gledhill, R. F., Harrison, B. M., & McDonald, W. I. (1973). Demyelination and
remyelination after acute spinal cord compression.
Experimental Neurology
,
38
, 472-487.
Grandpre, T., Li, S., & Strittmatter, S. M. (2002). Nogo-66 receptor antagonist peptide pro-
motes axonal regeneration.
Nature
,
417
, 547-551.
Grandpre, T., Nakamura, F., Vartanian, T., et al. (2000). Identification of the Nogo inhibitor
of axon regeneration as a Reticulon protein.
Nature
,
403
, 439-444.
Hulsebosch, C. E. (2002). Recent advances in pathophysiology and treatment of spinal cord
injury.
Advances in Physiology Education
,
26
, 238-255.
Illis, L. S. (2012). Central nervous system regeneration does not occur.
Spinal Cord
,
50
,
259-263.
